Data / Form D filings / PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc.: Form D filings
PanTher Therapeutics, Inc., a biotechnology company in Austin, TX, filed 10 Form D notices with the SEC between 2015 and 2025. The latest, on April 3, 2025, reports $3 million sold of a $5 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7000 Bee Caves Road, Suite 300, Austin, TX, 78746
- Phone
- (857) 413-1698
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1644045
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | New notice | $5,000,000 | $3,021,707 | $1,978,293 | 26 | Mar 14, 2025 | sec.gov |
| Dec 18, 2023 | New notice | $5,000,000 | $2,676,030 | $2,323,970 | 28 | Nov 30, 2023 | sec.gov |
| Dec 19, 2022 | New notice | $2,000,000 | $1,261,500 | $738,500 | 15 | Dec 5, 2022 | sec.gov |
| Jun 24, 2022 | New notice | $1,200,000 | $1,061,000 | $139,000 | 17 | Jun 1, 2022 | sec.gov |
| Jun 2, 2021 | Amendment | $7,334,474 | $7,334,474 | 59 | May 27, 2020 | sec.gov | |
| Jun 4, 2020 | New notice | $7,027,513 | $3,032,514 | $3,994,999 | 38 | May 27, 2020 | sec.gov |
| May 18, 2020 | New notice | $209,488 | $209,488 | 15 | Jun 10, 2019 | sec.gov | |
| May 14, 2020 | New notice | $268,061 | $268,061 | 6 | Aug 7, 2018 | sec.gov | |
| Nov 10, 2016 | New notice | $500,000 | $35,000 | $465,000 | 1 | Oct 28, 2016 | sec.gov |
| Jun 8, 2015 | New notice | $500,000 | $95,000 | $405,000 | 3 | Jun 1, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laura Indolfi | Executive Officer, Director | |
| D Mackey | Director | |
| Daniel Wildman | Director | |
| Darshana Zaveri | Director | |
| Maria Palasis | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PanTher Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.